Pet Financial News
Telix to Showcase ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline Developments at SNMMI
MELBOURNE, Australia, June 22, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reveals discussions from the Company's investigational prostate (prostate...
Pet Financial News
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, consisting of Japanese Sites
MELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reveals that it has...
Pet Financial News
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
MELBOURNE, Australia, May 7, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reveals that it has actually participated in...
- Advertisement -
Pet Financial News
Telix Acquires Optimum Tracers
MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ -- Telix Prescribed drugs Restricted (ASX: TLX, Telix, the Firm) at this time publicizes that it has...
Pet Financial News
Telix Gets Optimum Tracers
MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 13, 2022/ PRNewswire/-- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Business) today reveals that...
Pet Financial News
Telix Collaboration Broadens GE Health Care Immuno-Diagnostics Offering to the International Scientific Research Study Market
Brand-new arrangement includes 2 Telix investigational family pet imaging radiotracers to GE Health care's immuno-diagnostic portfolio, to allow client choice and tracking...
- Advertisement -
Pet Financial News
Telix Reports Third Quarter 2022 Financial Outcomes
MELBOURNE, Australia, Oct. 20, 2022/ PRNewswire/-- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Business) today provides its Appendix 4C quarterly capital...
-Advertisement-
Must read
-Advertisement-